Palbociclib 125 mg Capsules are prescription anticancer medicines used to treat hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced o…
Palbociclib 125 mg Capsules are prescription anticancer medicines used to treat hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer. Palbociclib works by inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6), helping slow the growth and division of cancer cells. It is generally used in combination with appropriate endocrine therapy.
Palbociclib 125 mg Capsules are oral targeted anticancer medicines belonging to the CDK4/6 inhibitor class. They selectively inhibit cyclin-dependent kinases 4 and 6, which regulate cell-cycle progression. This action prevents cancer cells from progressing from the G1 phase to the S phase of the cell cycle, thereby helping inhibit tumor cell proliferation.
Palbociclib is indicated for eligible adults with HR-positive, HER2-negative advanced or metastatic breast cancer, in combination with an aromatase inhibitor or fulvestrant, depending on the patient's treatment history and prescribed regimen. Treatment should be supervised by an oncologist, with regular monitoring of blood counts because the medicine can cause neutropenia and other adverse effects.
Palbociclib — 125 mg per capsule.
We offer reliable delivery across India and international markets. Domestic orders typically arrive within 5–7 business days. International shipping times vary by destination. All orders are carefully packaged to maintain product integrity and quality.
